The health, safety and well-being of our members, staff, exhibitors, faculty, patients and other stakeholders remain of paramount importance. With continued uncertainty surrounding the COVID-19 pandemic and travel advisories and restrictions still in place in the U.S. and globally, the College hopes the new dates will allow more people to attend ACC.21 in person. The exciting live program will provide unique opportunities to reimagine global heart health, refocus on science, and reconnect with colleagues from around the world.
Major meetings are years in the making so finding new dates on short notice poses many challenges. ACC was fortunate to be offered dates in May that became available.
While we hope more people can and will attend ACC.21 in person, we also understand that some members may have personal and/or professional conflicts in addition to ongoing concerns about COVID-19 safety. As a result, the ACC is absolutely committed to developing a robust ACC.21 Virtual program with on demand options that will ensure that members from around the world can participate and engage with the meeting at times and in ways that work for individual schedules. Look for more details on both options on the ACC Scientific Session website this fall. If you can't make it to ACC.21 in person, we look forward to seeing you in Washington, DC, for ACC.22.
Registration for both ACC.21 and ACC.21 Virtual will open in October. Look for announcements and more details in the coming weeks.
In addition, faculty invitations will also be sent in October to coordinate with the opening of registration.
The ACC.21 Abstract/Case Submission site will open in October. Submissions for LBCTs will open in early December. Look for more details on the submission process and deadlines on the in the coming weeks.